The contribution of the donor vascularised hand and face allograft in transplant rejection: An immunological perspective.

Direct presentation Passenger leukocyte Rejection Transplantation Vascularised composite allotransplantation

Journal

Transplant immunology
ISSN: 1878-5492
Titre abrégé: Transpl Immunol
Pays: Netherlands
ID NLM: 9309923

Informations de publication

Date de publication:
20 Mar 2024
Historique:
received: 29 09 2023
revised: 14 03 2024
accepted: 15 03 2024
medline: 23 3 2024
pubmed: 23 3 2024
entrez: 22 3 2024
Statut: aheadofprint

Résumé

Overcoming immunological rejection remains a barrier to the safe adoption of Vascularised Composite Allotransplantation (VCA). To mitigate this risk, clinical protocols have been derived from solid organ transplantation, targeting recipient immunomodulation, yet VCA is unique. Face and hand composite allografts are composed of multiple different tissues, each with their own immunological properties. Experimental work suggests that allografts carry variable numbers and populations of donor leukocytes in an organ specific manner. Ordinarily, these passenger leukocytes are transferred from the donor graft into the recipient circulation after transplantation. Whether alloantigen presentation manifests as acute allograft rejection or transplant tolerance is unknown. This review aims to characterise the immunological properties of the constituent parts of the donor face and hand, the potential fate of donor leukocytes and to consider theoretical graft specific interventions to mitigate early rejection.

Identifiants

pubmed: 38518826
pii: S0966-3274(24)00051-0
doi: 10.1016/j.trim.2024.102035
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102035

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Kavit R Amin (KR)

Department of Plastic Surgery, Manchester University NHS Foundation Trust, Manchester, UK; Division of Cell Matrix, Biology and Regenerative Medicine, University of Manchester, Manchester, UK. Electronic address: kavit.amin@manchester.ac.uk.

James E Fildes (JE)

The Pebble Institute, Styal, Manchester, UK; The Healthcare Technologies Institute, University of Birmingham, Birmingham, UK.

Classifications MeSH